MONITOR CANCER TREATMENT WITH FLIVO

About UsContact UsNewsletterSite MapHome
 
PricelistPricelistELISADistributorsMSDSFAQReferences
 

 

ATO induces apoptosis after only 3 hours of treatment.

39% of breast tumor cells under go apoptosis after treatment with ATO compared to 18% of untreated tumors.

Are you killing the tumor?
Find out with FLIVO™ to monitor the efficacy of chemotherapy.

FLIVO is an injectable in vivo detection reagent that labels apoptotic cells green or red in just 30 minutes prior to sacrifice. If the treatment induces apoptosis in tumor cells, it is probably effective at killing the tumor. Let FLIVO guide you to the most effective treatment within hours of administration. 

    Researchers can now quantify apoptosis in living animals using ICT’s new FLIVO™ fluorescent in vivo apoptosis detection kits. FLIVO™ is an injectable fluorescent probe used to quantitate apoptosis in live animals. It is a direct stain; once labeled, tissues are ready for analysis and no further processing is necessary. FLIVO™ is very easy to use. Just inject it into the animal and let it circulate 30-45 minutes. Apoptotic cells fluoresce green or red. View cells and tissues directly through a window chamber system or other accessible cavity, or sacrifice the animal and analyze cells with a fluorescent microscope, plate reader, or flow cytometer (see splenocyte data and tissue data). The tissues can be fixed or frozen for future analysis; protect from light during storage and handling.
    Because FLIVO™ is cell-permeant, it diffuses in and out of cells as it circulates throughout the body.  If there is an active caspase enzyme
inside the cell, it will form an irreversible covalent bond with FLIVO™

 
no killing yet
apoptosis before treatment
a very low level of caspase activity

 
lots of killing
apoptosis after 3 hours of treatment
a very high level of caspase activity

and retain the green or red fluorescent signal within the cell.  Any unbound reagent will be flushed back out of the cell with the natural circulation of the animal.  FLIVO™ appears to clear the circulation of the animal in about an hour.  We have successfully detected apoptosis in tumor tissues, splenocytes, bone marrow, brain, and eye tissue in mice. The reagent crosses the blood-brain barrier.
     FLIVO™ is very specific. Only active enzymes will covalently bind with the reagent, therefore only cells undergoing apoptosis will fluoresce. Since the FLIVO™ reagents do not use antibodies, they will not react with pro-caspases or inactive forms of the enzymes. FLIVO™ is very sensitive and will even detect background apoptosis, typically occurring in 2-6% of cells. Unlike annexin, FLIVO™ will not accumulate in non-apoptotic tissues, nor will it non-specifically bind to thymus-derived cells.
 
     ICT has 2 FLIVO™ kits to detect apoptosis in whole animals: chose red or green fluorescence.  ICT’s FLIVO™ reagents are comprised of 3 segments: a red (sulforhodamine, SR) or green (carboxyfluorescein, FAM) fluorescent label; a 3-amino acid peptide inhibitor sequence targeted by active caspases: valine, alanine, and aspartic acid (VAD); and a fluoromethylketone group (FMK) that allows the formation of a covalent bond with the active enzyme.  The green in vivo FAM-FLIVO™ probe excites at 492nm and emits at 520nm. The red in vivo SR-FLIVO™ probe excites at 565nm and emits at >600nm.


These pictures were taken through a window chamber of 1 live breast cancer tumor growing inside a mouse. Before any treatment was administered, FAM-FLIVO™  was injected into the mouse to determine how many of the tumor cells were apoptotic: caspase-positive cells turn green, caspase-negative cells are dark. The first picture (top) was taken 45 minutes after FAM-FLIVO™ was injected. Very few of the cells turned green, indicating that most of the tumor is living. The mouse was then injected with a drug (arsenic trioxide, ATO) for 3 hours. FAM-FLIVO™ was again injected into the mouse, and the second picture (bottom) was taken 45 minutes later. Within a few hours of treatment, Dr. Robert Griffin (U of MN) was able to assess the efficacy of the drug using FAM-FLIVO™: ATO induced apoptosis in most of the tumor cells. 

     Use FLIVO™ alongside labeled antibodies and other probes for dual-staining studies ex vivo.  The red SR-FLIVO™ reagent can be used with GFP-transfected cells. After labeling with FLIVO™, cells can be fixed, embedded, or frozen for storage. We recommend analyzing the tissues within 24 hours, as the fluorescent label will photobleach when exposed to light, however samples have been frozen for weeks and re-analyzed with equivalent results.
     To use the kit, reconstitute the reagent with 50uL DMSO, add 200uL filter-sterilized 1x injection buffer, and inject 40uL into each mouse.  FLIVO™ kits come in 2 sizes: small and large. The small kits contain 1 vial of FLIVO™, and large kits contain 4 vials (all FLIVO™ kits include injection buffer).  Based in our initial mouse model, 1 vial of reagent contains enough material to inject 6 mice.  Larger animals may require more reagent.  Set up an initial reagent titration experiment to determine of the amount of reagent that will work best for the size of your animal and tissue type. 
     FLIVO™ complements ICT’s FLICA™ in vitro apoptosis detection kits, which enable researchers to quantify apoptotic cells grown in culture. FLICA™ kits are available with green or red fluorescent probes to quantitate active caspase 1, 2, 3&7, 8, 9 10, 13, or all of them at once (poly caspases).

Don't set up another apoptosis experiment until you call us.  Order today 800-829-3194!

 
control animal; 18% of tumor cells have active caspases

 

test animal; 39% of tumor cells have active caspases

 

These pictures were taken of live tumors growing inside 2 different mice after injection with red SR-FLIVO™. The control mouse (left) received a placebo while the test mouse (right) was treated with ATO. 24 hours after treatment, both mice were injected intravenously with ICT’s red SR-FLIVO™ in the tail vein. Pictures were taken 30 minutes later. The control tumor exhibits some level of apoptosis as expected, whereas the ATO-treated mouse tumor exhibits a much higher level of apoptosis (it is brighter red). Areas with high levels of active caspases, and thus more bound fluorescence, appear as overexposed white spots in the image. Black areas are living tumor cells. To quantify the level of caspase activity and apoptosis, Dr. Robert Griffin (U of MN) excised the tumor, trypsinized the cells, and analyzed them on a flow cytometer (below).

 

Cell suspensions were made from excised mammary tumors (like those above) and analyzed on a flow cytometer. After labeling both tumors with FLIVO™, the level of apoptosis could be quantified: it doubled in SCK mammary tumors after treatment with ATO. 39% of tumor cells treated with ATO were apoptotic; 18% of untreated tumor cells were apoptotic. 

 

picture of kit

Green FLIVO™ kits contain: FAM-FLIVO™ reagent and injection buffer. Cat.# 980, 25 tests.
 

 

picture of kit

Red FLIVO™ kits contain: SR-FLIVO™ reagent and injection buffer. Cat.# 983, 100 tests. 
 


   

FLIVO™ Poly (Pan) Caspase in vivo
Apoptosis Detection Kits
(green & red fluorescent probes)

Color

small, 6 mice

large, 24 mice

Cat #   Price Cat #   Price
 

Green FAM- FLIVO™ Kit

980 $139.00 981 $389.00
 

Red SR- FLIVO™ Kit

982 $159.00 983 $399.00

 

FLIVO™ Kits:
Use whole animals Label apoptotic tissues before sacrifice so further manipulation of the tissues won't cause artifacts. 
Easy Just inject into the animal; no lysis or permeabilization steps.
Accurate FLIVO™ will not stain necrotic nor healthy tissues. 
Reliable Only cells with active caspase enzymes fluoresce; there is no interference from pro-caspases or inactive forms of the enzyme.  
Fast Let the reagent circulate 30-45 minutes. 
Direct Active caspases covalently bind to FLIVO™ which is fluorescent.  
Sensitive Detects background levels of apoptosis in controls. 
Safe Use red or green fluorescent probes instead of radioisotopes. 
Quantitative Analyze animals with a fluorescence microscope, whole animal imaging system, plate reader, or flow cytometer.
 

Data:
Experimental data summary sheet
Apoptosis detected in thymus, bone marrow, other tissues
Mammary tumors become apoptotic when treated with ATO
Splenocytes become apoptotic afte
r morphine treatment

Window chamber model of apoptosis detection
Data and protocol in the kit manual (call us 800-829-3194)

Sample protocol:
1. Expose your animals to your experimental condition, and create positive and negative controls if possible. 
2. Reconstitute the reagent with 50uL DMSO to form the stock concentrate (which can be frozen for future use). 
3. Dilute the injection buffer 1:10 with diH2O and sterilize by filtration.
4
. Add 200uL 1X injection buffer to the reagent. 
5. Inject ~40uL of diluted reagent into each mouse. 
6. Let circulate 30-45 minutes. 
7. Examine tissues under a fluorescent microscope, or sacrifice and excise cells.
8.
If desired, label cells with an additional stain, like 7AAD or labeled antibody.
9. If desired, fix, embed, or freeze cells. 
10. Analyze cells with a fluorescent microscope, plate reader or flow cytometer.

This protocol may be adjusted depending on your animal and target tissues.  For example, to increase the dose of FLIVO™ given to each animal, change steps 4 and 5.  In step 4, add 350uL injection buffer to the reagent, then in step 5, inject 100uL into each animal.


Prices & Catalog #s

Order today 800-829-3194!

Check out our other apoptosis kits:

FLICA™: detect apoptosis in cultured cells in vitro by adding the reagent directly to the media.

Magic Red™: detect apoptosis in real time by watching color develop.

MitoPT™: detect apoptosis via the mitochondrial membrane breakdown, correlating with cytochrome-c release.

Caspase antibodies and enzymes: use our purified reagents in the rest of your studies.

800-829-3194 About Us | Contact Us | Newsletter | Site Map | Home
Copyright 2006
                                    This page was updated on 09/20/2006 . Please contact us at 952-888-8788.